Article 118(1) read in combination with Article 107(2) of Regulation (EU) 2019/6 of the European Parliament and of the Council [Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43, ELI: http://data.europa.eu/eli/reg/2019/6/oj).] establishes that operators in third countries are not to use antimicrobial medicinal products in animals to promote growth or increase yield. From Article 118(1) of Regulation (EU) 2019/6 it follows that also medicinal products containing antimicrobials that are included in the list of antimicrobials reserved for the treatment of certain infections in humans laid down in Commission Implementing Regulation (EU) 2022/1255 [Commission Implementing Regulation (EU) 2022/1255 of 19 July 2022 designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council (OJ L 191, 20.7.2022, p. 58, ELI: http://data.europa.eu/eli/reg_impl/2022/1255/oj).] are not to be used in respect of animals or products of animal origin exported from third countries to the Union.
Recital 3, Decision_act (EU) 2026/1205
In forcesince 9 Jun 2026
- celex=32001L0082
- celex=32019R6118